Pharmacological treatment of coronary artery disease
| dc.contributor.advisor | Pórszász, Róbert | |
| dc.contributor.advisordept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | |
| dc.contributor.author | Adamoh, Hasbiallah Oluwatobi | |
| dc.contributor.department | DE--Általános Orvostudományi Kar | |
| dc.contributor.opponent | Drimba, László | |
| dc.contributor.opponent | Szentmiklósi, József András | |
| dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar::Aneszteziológiai és Intenzív Terápiás Tanszék | |
| dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | |
| dc.date.accessioned | 2022-11-15T08:05:32Z | |
| dc.date.available | 2022-11-15T08:05:32Z | |
| dc.date.created | 2022 | |
| dc.description.abstract | This thesis highlights an overview of the epidemiology, risk factors, pathomechanism and diagnosis, with special attention to pharmacological strategies involved in the treatment of CAD. Symptomatic alleviation and secondary prophylaxis of coronary artery disease are the goals of pharmacological treatment. Medical management remains the cornerstone of care, however, with persistent symptoms and drug intolerance, revascularization through procedures like percutaneous coronary intervention and coronary artery bypass graft, have a significant impact. in addition, risk assessment and prevention strategies are also discussed in detail. | |
| dc.description.course | általános orvos | |
| dc.description.courselang | angol | |
| dc.description.degree | egységes, osztatlan | |
| dc.format.extent | 35 | |
| dc.identifier.uri | https://hdl.handle.net/2437/339810 | |
| dc.language.iso | en | |
| dc.subject | coronary artery disease | |
| dc.subject | ace inhibitors | |
| dc.subject | antiplatelet drugs | |
| dc.subject.dspace | DEENK Témalista::Orvostudomány::Farmakológia | |
| dc.title | Pharmacological treatment of coronary artery disease |